Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
8.48
0.00 (0.00%)
Nov 18, 2025, 3:30 PM EST - Market open
Intellia Therapeutics Market Cap
Intellia Therapeutics has a market cap or net worth of $982.24 million as of November 18, 2025. Its market cap has decreased by -32.00% in one year.
Market Cap
982.24M
Enterprise Value
425.98M
1-Year Change
-32.00%
Ranking
Category
Stock Price
$8.48
Market Cap Chart
Since May 6, 2016, Intellia Therapeutics's market cap has increased from $757.50M to $982.24M, an increase of 29.67%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 982.20M | -17.30% |
| Dec 31, 2024 | 1.19B | -56.51% |
| Dec 29, 2023 | 2.73B | -0.54% |
| Dec 30, 2022 | 2.75B | -68.80% |
| Dec 31, 2021 | 8.80B | 173.78% |
| Dec 31, 2020 | 3.21B | 348.19% |
| Dec 31, 2019 | 717.10M | 20.99% |
| Dec 31, 2018 | 592.70M | -14.55% |
| Dec 29, 2017 | 693.60M | 46.98% |
| Dec 30, 2016 | 471.90M | -37.70% |
| May 6, 2016 | 757.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.66B |
| Johnson & Johnson | 481.09B |
| AbbVie | 413.39B |
| UnitedHealth Group | 285.46B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 232.71B |
| Abbott Laboratories | 228.84B |